Ефективність та безпечність періопераційного застосування статинів при проведенні аортокоронарного шунтування

І.В. Шклянка, О.Й. Жарінов, К.О. Міхалєв, О.А. Єпанчінцева, Б.М. Тодуров

Література 

1. Lyakh YuE, Guryanov VG, Khomenko VN, Panchenko OA. Basics of Computer Biostatistics. Analysis of information in biology, medicine and pharmacy statistical package Medstat. Donetsk, 2006. 214 p. (in Russ.).
2. Todurov BM, Zharinov OYe, Okpanchintseva OA. et al. Paroxysmal atrial fibrillation early in postoperative aortic coronary artery bypass grafting. Ukr J Cardiol. 2011;2:96-101. (in Ukr.).
3. Auer J, Weber T, Berent R. et al. Postoperative atrial fibrillation independently predicts prolongation of hospital stay after cardiac surgery. Cardiovasc Surg. 2005;46:583-588.
4. Barakat AF, Saad M, Abuzaid A. et al. Perioperative Statin Therapy for Patients Undergoing Coronary Artery Bypass Grafting. Ann Thorac Surg. 2016;101(2):818-825.
5. Caorsi C, Pineda F, Munoz C. Pravastatin immunomodulates IL-6 and C-reactive protein, but not IL-1 and TNF-alpha, in cardio-pulmonary bypass. Eur Cytokine Netw. 2008;19(2):99-103.
6. Christenson JT. Preoperative lipid-control with simvastatin reduces the risk of postoperative thrombocytosis and thrombotic complications following CABG. Eur J Cardiothorac Surg. 1999;15:394-400.
7. De Waal BA, Buise MP, Van Zundert AAJ. Perioperative statin therapy in patients at high risk for cardiovascular morbidity undergoing surgery. Br J Anaesth. 2015;114(1):44-52.
8. Eknoyan G, Lameire N. KDIGO 2012 Clinical practice guideline for the evaluation and management of chronic kidney disease. Off J Intern Soc Nephrology. 2013;3(1):1-150.
9. Filion KB, Pilote L, Rahme E. et al. Use of perioperative cardiac medical therapy among patients undergoing coronary artery bypass graft surgery. J Card Surg. 2008;23:209-215.
10. Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplantation. 2013;48:452-458.
11. Kang S, Liu Y, Liu X.B. Effects of aggressive statin therapy on patients with coronary saphenous vein bypass grafts: a systematic review and meta-analysis of randomized, controlled trials. Clin Ther. 2013;35(8):1125-1136.
12. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Inter. 2012;2 (Suppl.):1-138.
13. Kuhn EW, Slottosch I, Wahlers T, Liakopoulos OJ. Preoperative statin therapy for patients undergoing cardiac surgery. Cochrane Database of Systematic Reviews. 2015;8. CD008493.
14. Kulik A, Ruel M, Jneid H. et al. American Heart Association Council on Cardiovascular Surgery and Anesthesia. Secondary prevention after coronary artery bypass graft surgery: a scientific statement from the American Heart Association. Circulation. 2015;131(10):927-964.
15. Landoni G, Casso G, Gallo M. et al. Perioperative statin therapy in cardiac surgery: a meta-analysis of randomized controlled trials. Critісаl Care. 2016;20:395.
16. Liakopoulos OJ, Choi YH, Haldenwang PL. et al. Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: a meta-analysis of over 30 000 patients. Eur Heart J. 2008;29(12):1548-1559.
17. Loppnow H, Zhang L, Buerke M. et al. Statins potently reduce the cytokine-mediated IL-6 release in SMC/MNC cocultures. J Cell Mol Med. 2011;15(4):994-1004.
18. Mills EJ, Wu P, Chong G. et al. Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170,255 patients from 76 randomized trials. QJM. 2011;104(2):109-124.
19. Montalescot G, Sechtem U, Achenbach S. et al. 2013 ESC guidelines on the management of stable coronary artery disease. The task force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34:2949-3003.
20. Najmeddine E, Pibarot P, O’Hara G, Mathieu P. Mechanisms, prevention, and treatment of atrial fibrillation after cardiacsurgery. J Amer Coll Cardiology. 2008;51(8):797-800.
21. Poldermans D, Bax JJ, Boersma E. et al. Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. Eur Heart J. 2009;30 (22):2769-2812.
22. Tandon V, Bano G, Khajuria V. et al. Pleiotropic effects of statins. Indian J Pharmacology. 2005;37(2):77-85.
23. Williams TM, Harken AH. Statins for surgical patients. Ann Surg. 2008;247:30-37.
24. Windecker S, Kolh P, Alfonso F. et al. 2014 ESC/EACTS Guidelines on myocardial revascularization. The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur J Cardiothorac. Surg. 2014;46(4):517-592.
25. Zheng Z, Jayaram R, Jiang L. et al. Perioperative Rosuvastatin in Cardiac Surgery. New Engl J Med. 2016;374:1744-1753.

 

[PDF] [Зміст журналу]